Advanced cervix cancer patient with chemotherapy-induced grade IV myelosuppression achieved complete remission with cadonilimab: A case report

Table 1 Trends in of tumor indicators and thyroid function

Measurement	07/08/2022	08/27/2020	10/28/2022	01/28/2023	02/04/2023	04/27/2023	07/24/2023
CEA (ng/mL)	146	22.5	3.5	2.68	8.23	5.95	7.69
CA125 (IU/mL)	94	17.3	16.3	10.2	14.3	14	13.6
CA199 (IU/mL)	83.1	18.4	17.5	38.9	36.4	28.4	30.6
SCCA (ng/mL)	0.754	0.776	0.989	1.23	0.96	1.07	0.985
T3 (nmol/mL)	1.69	1.01	1.37	0.71	0.97	0.95	0.93
T4 (nmol/mL)	89.8	62.9	74.2	22.2	45.2	58.1	46.5
TSH (µIU/mL)	33.8	90.1	92.1	> 100	> 100	> 100	> 100
TPO-Ab (IU/mL)	996	> 1000	993	> 1000	900	785	320